A previous study found that 10 cell proliferation genes, including BUB1, CCNB2, and CDK1, could act as indicators for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma [43]. This evidence concerns the gene BUB1 and renal cell carcinoma.